You have 9 free searches left this month | for more free features.

P300

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Attention Trial in Maynooth (Task difficulty adaptation according to Arvaneh et al. (2019), Random task difficulty, Task

Recruiting
  • Attention
  • Task difficulty adaptation according to Arvaneh et al. (2019)
  • +2 more
  • Maynooth, Co. Kildare, Ireland
    Maynooth University
Oct 9, 2022

Castrate Resistant Prostate Cancer, NUT Carcinoma Trial (EP31670)

Not yet recruiting
  • Castrate Resistant Prostate Cancer
  • NUT Carcinoma
  • (no location specified)
Aug 3, 2022

Sensorineural Hearing Loss, Hearing Loss Trial in Lebanon (P300 Visually evoked potential)

Recruiting
  • Sensorineural Hearing Loss
  • Hearing Loss
  • P300 Visually evoked potential
  • Lebanon, New Hampshire
    Dartmouth Hitchcock Medical Center
Feb 8, 2022

Gynecologic Disease Trial in Zagazig ( capsule (vitamin c), Group pregabalin 150, Group pregabalin 300)

Recruiting
  • Gynecologic Disease
  • placebo capsule (vitamin c)
  • +2 more
  • Zagazig, Elsharqya, Egypt
    faculty of medicine, Zagazig university
Sep 2, 2021

Bipolar Anhedonic Depression Trial in Rouen, St Etienne Du Rouvray (Electroencephalogram, walking test, Quality of life

Recruiting
  • Bipolar Anhedonic Depression
  • Electroencephalogram
  • +3 more
  • Rouen, France
  • +1 more
Nov 27, 2020

Drug Interaction Trial in Montréal (ATI-2173 50 mg, Tenofovir 300Mg Oral Tablet)

Completed
  • Drug Interaction
  • ATI-2173 50 mg
  • Tenofovir 300Mg Oral Tablet
  • Montréal, Quebec, Canada
    Altasciences
Feb 3, 2022

EoE, Eosinophilic Esophagitis Trial in United States (Mepolizumab 300 mg, Mepolizumab 100 mg, Placebo)

Completed
  • EoE
  • Eosinophilic Esophagitis
  • Mepolizumab 300 mg
  • +2 more
  • Chicago, Illinois
  • +3 more
Dec 20, 2022

Chronic Rhinosinusitis With Nasal Polyps Trial in Montreal (Dupilumab 300 MG in 2 ML Prefilled Syringe, Placebo, Mometasone

Recruiting
  • Chronic Rhinosinusitis With Nasal Polyps
  • Dupilumab 300 MG in 2 ML Prefilled Syringe
  • +2 more
  • Montreal, Quebec, Canada
    Centre Hospitalier de l'Université de Montréal (CHUM)
Nov 10, 2022

LLIN, PBO LLIN, IRS, Larviciding Trial in Irvine, Homa Bay (Regular long-lasting insecticidal nets, LLIN plus Piperonyl

Recruiting
  • LLIN, PBO LLIN, IRS, Larviciding
  • Regular long-lasting insecticidal nets
  • +3 more
  • Irvine, California
  • +1 more
Feb 1, 2023

P300 in Early Cognitive Impairment in Hepatitis C Virus

Completed
  • Hepatitis C
  • Cognitive Impairment
  • Visual Event-Related Potentials
  • Mansoura, Egypt
    Mansoura University Hospital
May 12, 2020

Hearing Loss, Sensorineural, Deafness Trial (P300 - Auditory long latency potential)

Unknown status
  • Hearing Loss, Sensorineural
  • Deafness
  • P300 - Auditory long latency potential
  • (no location specified)
Mar 30, 2020

Duchenne and Becker Muscular Dystrophy, Polycytemia Vera Trial in Québec (ITF2357 10 mg/mL, Placebo, Moxifloxacin Hydrochloride)

Completed
  • Duchenne and Becker Muscular Dystrophy
  • Polycytemia Vera
  • ITF2357 10 mg/mL
  • +2 more
  • Québec, Canada
    Québec
Aug 25, 2021

Post-operative Pain Trial in Brussels (Scalp electroencephalography (EEG), Laser-evoked potentials (LEPs), Cognitive

Not yet recruiting
  • Post-operative Pain
  • Scalp electroencephalography (EEG)
  • +9 more
  • Brussels, Belgium
    Cliniques universitaires Saint-Luc
Feb 2, 2021

People Who Have Genetic Changes and Features of Autism: Simons

Recruiting
  • 16P11.2 Deletion Syndrome
  • +184 more
    • New York, New York
    • +1 more
    Jan 6, 2023

    HIV-1-infection Trial in United States (426c.Mod.Core-C4b 30 mcg, 426c.Mod.Core-C4b 100 mcg, 426c.Mod.Core-C4b 300 mcg)

    Recruiting
    • HIV-1-infection
    • 426c.Mod.Core-C4b 30 mcg
    • +3 more
    • Birmingham, Alabama
    • +5 more
    Jul 25, 2022

    Acute Myocardial Infarction, STEMI, Percutaneous Coronary Revascularization Trial in Worldwide (FDY-5301, Placebo)

    Recruiting
    • Acute Myocardial Infarction
    • +2 more
    • Torrance, California
    • +15 more
    Aug 8, 2022

    Patients With Complicated Urinary Tract Infections Caused by P. Aeruginosa, Pseudomonas Aeruginosa, Pseudomonas Infections Trial

    Unknown status
    • Patients With Complicated Urinary Tract Infections Caused by P. Aeruginosa
    • +3 more
    • Ftortiazinon (tablets 300 mg) 1/2 dose +placebo+ Maxipim
    • +2 more
    • Saint Petersburg, Russian Federation
    • +4 more
    Jan 13, 2021

    Postoperative Pain Trial in Monastir (Pregabalin 150mg, Placebos, Pregabalin 300mg)

    Completed
    • Postoperative Pain
    • Pregabalin 150mg
    • +2 more
    • Monastir, Tunisia
      Monastir maternity and neonatology center
    Feb 4, 2020

    Plaque Psoriasis Trial in Worldwide (biological, radiation, drug)

    Recruiting
    • Plaque Psoriasis
    • Secukinumab
    • +3 more
    • Ciudad Autonoma de Bs As, Buenos Aires, Argentina
    • +66 more
    Jul 20, 2022

    Emotional and Neutral Sounds for Neurophysiological Prognostic

    Not yet recruiting
    • Disorder of Consciousness
    • Use of "expressive" sounds
    • Paris, Ile De France, France
      Medical ICU, Cochin Hospital, APHP.Centre
    Feb 22, 2023

    Male Hypogonadism Trial in Torrance, Quebec City (Oral testosterone undecanoate (containing 300 mg T))

    Completed
    • Male Hypogonadism
    • Oral testosterone undecanoate (containing 300 mg T)
    • Torrance, California
    • +1 more
    Nov 6, 2020

    Neovascular Age-Related Macular Degeneration Trial in United States (hI-con1™ 60µl, hI-con1™ 150µl, hI-con1™ 300µl)

    Completed
    • Neovascular Age-Related Macular Degeneration
    • hI-con1™ 60µl
    • +2 more
    • Missoula, Montana
    • +4 more
    Oct 15, 2020

    Colo-rectal Cancer Trial in Worldwide (Arfolitixorin, Leucovorin)

    Active, not recruiting
    • Colo-rectal Cancer
    • Gilbert, Arizona
    • +93 more
    Mar 29, 2022

    Hand Eczema Trial in Worldwide (Ruxolitinib cream, Vehicle)

    Withdrawn
    • Hand Eczema
    • Phoenix, Arizona
    • +48 more
    Nov 14, 2022

    Atopic Dermatitis Trial in Worldwide (LY3454738, Placebo)

    Not yet recruiting
    • Atopic Dermatitis
    • Fort Smith, Arkansas
    • +55 more
    Jun 12, 2023